NasdaqCM - Delayed Quote • USD
Arcadia Biosciences, Inc. (RKDA)
At close: 4:00 PM EDT
After hours: 5:12 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 1 |
Avg. Estimate | -2.21 | -1.56 | -5.61 | -4.61 |
Low Estimate | -2.52 | -1.65 | -6.22 | -4.61 |
High Estimate | -1.91 | -1.47 | -5.01 | -4.61 |
Year Ago EPS | -10.86 | -2.65 | -16.59 | -5.61 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 1 |
Avg. Estimate | 1.19M | 1.43M | 6.22M | 8M |
Low Estimate | 1.19M | 1.4M | 6M | 8M |
High Estimate | 1.2M | 1.45M | 6.45M | 8M |
Year Ago Sales | 1.51M | 1.82M | 5.33M | 6.22M |
Sales Growth (year/est) | -21.10% | -21.40% | 16.70% | 28.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -6.85 | -4.8 | -3.19 | -2.58 |
EPS Actual | -10.86 | -2.65 | -1.44 | -2.52 |
Difference | -4.01 | 2.15 | 1.75 | 0.06 |
Surprise % | -58.50% | 44.80% | 54.90% | 2.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -2.21 | -1.56 | -5.61 | -4.61 |
7 Days Ago | -2.21 | -1.56 | -5.61 | -4.61 |
30 Days Ago | -2.29 | -1.61 | -5.74 | 5.49 |
60 Days Ago | -2.29 | -1.61 | -5.74 | 5.49 |
90 Days Ago | -2.29 | -1.61 | -5.74 | 5.49 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 2 | 1 | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | RKDA | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 79.70% | -- | -- | 6.50% |
Next Qtr. | 41.10% | -- | -- | 12.00% |
Current Year | 66.20% | -- | -- | 5.30% |
Next Year | 17.80% | -- | -- | 13.10% |
Next 5 Years (per annum) | 14.96% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/5/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 8/28/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 7/24/2023 |
Maintains | HC Wainwright & Co.: Buy to Buy | 6/5/2023 |
Maintains | HC Wainwright & Co.: Buy | 4/14/2023 |
Related Tickers
NUZE NuZee, Inc.
1.6300
+33.61%
GLUC Glucose Health, Inc.
0.4446
-11.09%
BSFC Blue Star Foods Corp.
0.0635
-0.47%
FREE Whole Earth Brands, Inc.
4.8200
0.00%
FTLF FitLife Brands, Inc.
28.72
+4.15%
UNBL.PA Unibel S.A.
950.00
0.00%
EWLU Merion, Inc.
0.0001
0.00%
KIKOF Kikkoman Corporation
12.90
0.00%
FF.MI Fine Foods & Pharmaceuticals N.T.M. S.p.A.
8.40
+0.48%
CYAN Cyanotech Corporation
0.2999
-0.20%